Ambulatory blood pressure monitoring tolerability and blood pressure status in adolescents: the SHIP AHOY study.
Journal
Blood pressure monitoring
ISSN: 1473-5725
Titre abrégé: Blood Press Monit
Pays: England
ID NLM: 9606438
Informations de publication
Date de publication:
Feb 2019
Feb 2019
Historique:
pubmed:
20
11
2018
medline:
7
3
2019
entrez:
20
11
2018
Statut:
ppublish
Résumé
Ambulatory blood pressure monitoring (ABPM) provides a more precise assessment of blood pressure (BP) status than clinic BP and is currently recommended in the evaluation of elevated BP in children and adolescents. Yet, ABPM can be uncomfortable for patients and cumbersome to perform. Evaluation of the tolerability to ABPM in 232 adolescent participants (median age: 15.7 years, 64% white, 16% Hispanic, 53% male) in the Study of Hypertension In Pediatrics Adult Hypertension Onset in Youth and its potential effects on ABPM results. Ambulatory BP status (normal vs. hypertension) was determined by sex and height-specific pediatric cut-points. Participants were asked to rank their wake and sleep tolerability to ABPM from 1 (most tolerant) to 10 (least tolerant); those with tolerability score of at least 8 were considered ABPM intolerant. Forty-three (19%) participants had wake ambulatory hypertension (HTN), 42 (18%) had sleep ambulatory HTN, and 64 (28%) had overall (wake and/or sleep) ambulatory HTN. Forty (17%) participants were intolerant to ABPM during wake hours and 58 (25%) were intolerant during sleep. ABPM intolerance during wake (but not sleep) hours was independently associated with wake (odds ratio: 2.34, 95% confidence interval: 1.01-5.39) and overall (odds ratio: 2.94, 95% confidence interval: 1.21-7.18) ambulatory HTN. Poor tolerability to ABPM is associated with a higher prevalence of ambulatory HTN in adolescents, and should be taken into consideration at time of ABPM interpretation.
Sections du résumé
BACKGROUND
BACKGROUND
Ambulatory blood pressure monitoring (ABPM) provides a more precise assessment of blood pressure (BP) status than clinic BP and is currently recommended in the evaluation of elevated BP in children and adolescents. Yet, ABPM can be uncomfortable for patients and cumbersome to perform.
OBJECTIVE
OBJECTIVE
Evaluation of the tolerability to ABPM in 232 adolescent participants (median age: 15.7 years, 64% white, 16% Hispanic, 53% male) in the Study of Hypertension In Pediatrics Adult Hypertension Onset in Youth and its potential effects on ABPM results.
PARTICIPANTS AND METHODS
METHODS
Ambulatory BP status (normal vs. hypertension) was determined by sex and height-specific pediatric cut-points. Participants were asked to rank their wake and sleep tolerability to ABPM from 1 (most tolerant) to 10 (least tolerant); those with tolerability score of at least 8 were considered ABPM intolerant.
RESULTS
RESULTS
Forty-three (19%) participants had wake ambulatory hypertension (HTN), 42 (18%) had sleep ambulatory HTN, and 64 (28%) had overall (wake and/or sleep) ambulatory HTN. Forty (17%) participants were intolerant to ABPM during wake hours and 58 (25%) were intolerant during sleep. ABPM intolerance during wake (but not sleep) hours was independently associated with wake (odds ratio: 2.34, 95% confidence interval: 1.01-5.39) and overall (odds ratio: 2.94, 95% confidence interval: 1.21-7.18) ambulatory HTN.
CONCLUSION
CONCLUSIONS
Poor tolerability to ABPM is associated with a higher prevalence of ambulatory HTN in adolescents, and should be taken into consideration at time of ABPM interpretation.
Identifiants
pubmed: 30451702
doi: 10.1097/MBP.0000000000000354
pmc: PMC6398596
mid: NIHMS1511337
doi:
Types de publication
Clinical Trial
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
12-17Subventions
Organisme : NCATS NIH HHS
ID : UL1 TR000042
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001425
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002001
Pays : United States
Références
Am J Hypertens. 1999 Sep;12(9 Pt 1):929-33
pubmed: 10509553
Pediatr Nephrol. 2000 Aug;14(8-9):802-5
pubmed: 10955931
Am J Hypertens. 2000 Sep;13(9):1035-8
pubmed: 10981556
Hypertension. 2002 Apr;39(4):903-8
pubmed: 11967247
BMJ. 2002 Aug 3;325(7358):258-9
pubmed: 12153924
J Hypertens. 2002 Oct;20(10):1995-2007
pubmed: 12359978
N Engl J Med. 2003 Jun 12;348(24):2407-15
pubmed: 12802026
J Pain. 2003 Sep;4(7):407-14
pubmed: 14622683
Pediatrics. 2004 Aug;114(2 Suppl 4th Report):555-76
pubmed: 15286277
Pediatr Nephrol. 2004 Dec;19(12):1379-84
pubmed: 15503182
Hypertension. 2005 Apr;45(4):493-8
pubmed: 15767467
Blood Press Monit. 2005 Jun;10(3):151-5
pubmed: 15923817
Hypertension. 2005 Jul;46(1):156-61
pubmed: 15939805
Pediatr Nephrol. 2005 Aug;20(8):1151-5
pubmed: 15947982
Hypertension. 2006 Jul;48(1):40-4
pubmed: 16735644
Hypertension. 2007 Apr;49(4):777-83
pubmed: 17261645
J Pediatr. 1991 Jun;118(6):842-9
pubmed: 2040918
Cardiol Young. 2011 Jun;21(3):310-6
pubmed: 21262077
BMC Med Res Methodol. 2011 Apr 27;11:59
pubmed: 21524301
Hypertension. 2012 Jul;60(1):43-50
pubmed: 22585950
Pediatr Nephrol. 2013 Jul;28(7):1059-66
pubmed: 23138756
Pediatr Nephrol. 2013 Aug;28(8):1275-82
pubmed: 23564040
Hypertension. 2014 May;63(5):1116-35
pubmed: 24591341
J Clin Hypertens (Greenwich). 2015 Oct;17(10):760-6
pubmed: 26140344
Pediatrics. 2017 Sep;140(3):null
pubmed: 28827377
Hypertension. 2018 Sep;72(3):625-631
pubmed: 29987102
J Pediatr. 1987 Sep;111(3):397-400
pubmed: 3625408
Arch Dis Child. 1987 Nov;62(11):1130-5
pubmed: 3688917
J Hum Hypertens. 1996 Sep;10 Suppl 3:S39-42
pubmed: 8872824
Am J Hypertens. 1998 Apr;11(4 Pt 1):410-7
pubmed: 9607378